Analytical Data
-
基因名
TP53BP1
- Application
-
别名
53BP1; p53BP1; p202
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q12888
-
表达区间
Leu1724~Lys1964
-
分子量
31kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TP53BP1 (Tumor Protein p53 Binding Protein 1) is a critical protein involved in the cellular response to DNA damage and plays a significant role in maintaining genomic stability. It is primarily known for its function in the DNA repair pathway, particularly in recognizing and responding to double-strand breaks through its interaction with the p53 tumor suppressor protein. The relevance of TP53BP1 has gained attention due to its implications in cancer biology, where mutations or dysregulation can lead to tumorigenesis and affect the efficacy of cancer therapies. Research into recombinant TP53BP1 has become a focal point for understanding its structural and functional properties, which may facilitate the development of novel therapeutic strategies targeting DNA repair mechanisms. Advancements in techniques such as gene editing and protein engineering allow scientists to create recombinant forms of TP53BP1 for detailed study, exploring aspects such as its interaction with other proteins, its role in the DNA damage response (DDR), and how it influences cell cycle regulation. Moreover, understanding TP53BP1's function in various cancer types could unveil potential biomarkers for prognosis and treatment response, making it a pivotal target in the pursuit of personalized medicine. As such, the detailed exploration of recombinant TP53BP1 not only contributes to fundamental knowledge in molecular biology but also holds promise for innovative cancer therapies and improved patient outcomes.












